S E Nissen
Overview
Explore the profile of S E Nissen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
100
Citations
2586
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeomans N, Graham D, Husni M, Solomon D, Stevens T, Vargo J, et al.
Aliment Pharmacol Ther
. 2018 Apr;
47(11):1453-1463.
PMID: 29667211
Aim: To evaluate GI safety of celecoxib compared with 2 nonselective (ns) NSAIDs, as a secondary objective of a large trial examining multiorgan safety. Methods: This randomised, double-blind controlled trial...
2.
Friedrich S, Kastelein J, James D, Waterhouse T, Nissen S, Nicholls S, et al.
CPT Pharmacometrics Syst Pharmacol
. 2014 Jan;
3:e94.
PMID: 24452615
Evacetrapib is a novel cholesteryl ester transfer protein (CETP) inhibitor currently being evaluated in a late-stage cardiovascular outcome trial. Using population-based models, we analyzed evacetrapib concentration data along with high-density...
3.
Sipahi I, Tuzcu E, Moon K, Nicholls S, Schoenhagen P, Zhitnik J, et al.
Heart
. 2007 Dec;
94(5):623-7.
PMID: 18070944
Objective: Despite the link between positive coronary remodelling and acute ischaemic events, no data exist about the impact of arterial remodelling on subsequent progression of coronary atherosclerosis. The objective of...
4.
Schoenhagen P, White R, Nissen S, Tuzcu E
Z Kardiol
. 2003 Jun;
92(6):429-37.
PMID: 12819991
Selective coronary angiography allows the precise definition of highly stenotic coronary lesions and therefore remains the basis for catheter-based or surgical myocardial revascularization. However, the accumulation of atherosclerotic plaque in...
5.
Tsutsui H, Schoenhagen P, Klingensmith J, Vince D, Nissen S, Tuzcu E
Circulation
. 2001 Dec;
104(23):2874.
PMID: 11733409
No abstract available.
6.
Mukherjee D, Nissen S, Topol E
Cleve Clin J Med
. 2001 Nov;
68(11):963-4.
PMID: 11718438
No abstract available.
7.
De Franco A, Nissen S
Am J Cardiol
. 2001 Nov;
88(10A):7M-20M.
PMID: 11705417
The incremental value of intravascular ultrasound (IVUS), compared with angiographic analysis of coronary atherosclerosis, originates principally from 2 key features-its tomographic perspective and the ability to image coronary atheroma directly....
8.
9.
Schoenhagen P, Vince D, Ziada K, Tsutsui H, Jeremias A, Crowe T, et al.
Am J Cardiol
. 2001 Oct;
88(7):785-7.
PMID: 11589850
No abstract available.
10.
Mukherjee D, Nissen S, Topol E
JAMA
. 2001 Aug;
286(8):954-9.
PMID: 11509060
Atherosclerosis is a process with inflammatory features and selective cyclooxygenase 2 (COX-2) inhibitors may potentially have antiatherogenic effects by virtue of inhibiting inflammation. However, by decreasing vasodilatory and antiaggregatory prostacyclin...